COVID-19 infection is associated with ischemic and hemorrhagic spinal stroke, with distinct clinical characteristics and underlying mechanisms.

Longer-term exposure to testosterone therapy was associated with an increased risk for major adverse cardiovascular events among men.

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

Lifestyle changes are associated with modest improvements in sperm motility and morphology among men with obesity.

Potentially harmful alcohol use can be detected via MAP, heart rate, and an abnormal P-wave axis among patients that consume alcohol.

There is decreased use of OACs among patients with newly diagnosed AF whose physicians underestimate their thromboembolic risk.

Patients with undiagnosed sleep disordered breathing and hypertrophic cardiomyopathy may have subclinical myocardial injury.

Serena Williams has endorsed GLP-1 medications, raising questions regarding their stigma and performance-enhancing potential for athletes.

Researchers sought to determine the most appropriate P2Y12 inhibitor therapy in patients with acute coronary syndrome.

For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not offer superior stroke protection versus aspirin.

In patients with ACS receiving PCI, periprocedural GLP-1RA therapy is associated with decreased mortality risk.

A scientific statement on the relationship between circadian health and cardiometabolic health and disease risk has been published by the AHA.